Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy.
Baden MY, Imagawa A, Abiru N, Awata T, Ikegami H, Uchigata Y, Oikawa Y, Osawa H, Kajio H, Kawasaki E, Kawabata Y, Kozawa J, Shimada A, Takahashi K, Tanaka S, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kobayashi T, Hanafusa T; consultation of the Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research.
Baden MY, et al. Among authors: kawasaki e.
Diabetol Int. 2018 Jul 3;10(1):58-66. doi: 10.1007/s13340-018-0362-2. eCollection 2019 Jan.
Diabetol Int. 2018.
PMID: 30800564
Free PMC article.